Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1998 2
1999 2
2001 2
2004 2
2005 1
2006 3
2007 1
2008 1
2009 1
2010 2
2011 2
2012 1
2013 2
2018 2
2019 3
2020 6
2021 5
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial.
Harrison TW, Chanez P, Menzella F, Canonica GW, Louis R, Cosio BG, Lugogo NL, Mohan A, Burden A, McDermott L, Garcia Gil E, Zangrilli JG; ANDHI study investigators. Harrison TW, et al. Lancet Respir Med. 2021 Mar;9(3):260-274. doi: 10.1016/S2213-2600(20)30414-8. Epub 2020 Dec 22. Lancet Respir Med. 2021. PMID: 33357499 Clinical Trial.
Predictors of severe COVID-19 in a registry-based Swedish cohort of patients with COPD.
Stridsman C, Vanfleteren LEGW, Konradsen JR, Axelsson Fisk S, Pedroletti C, Sjöö Y, Syk J, Sterner T, Lindberg A, Tunsäter A, Nyberg F, Ekberg-Jansson A, Karlsson Sundbaum J. Stridsman C, et al. Among authors: tunsater a. Eur Respir J. 2021 Nov 11;58(5):2101920. doi: 10.1183/13993003.01920-2021. Print 2021 Nov. Eur Respir J. 2021. PMID: 34413151 Free PMC article.
Uncontrolled asthma predicts severe COVID-19: a report from the Swedish National Airway Register.
Karlsson Sundbaum J, Konradsen JR, Vanfleteren LEGW, Axelsson Fisk S, Pedroletti C, Sjöö Y, Syk J, Sterner T, Lindberg A, Tunsäter A, Nyberg F, Ekberg-Jansson A, Stridsman C. Karlsson Sundbaum J, et al. Among authors: tunsater a. Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666221091183. doi: 10.1177/17534666221091183. Ther Adv Respir Dis. 2022. PMID: 35430944 Free PMC article.
Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy.
Louis R, Harrison TW, Chanez P, Menzella F, Philteos G, Cosio BG, Lugogo NL, de Luiz G, Burden A, Adlington T, Keeling N, Kwiatek J, Garcia Gil E; ANDHI Study Investigators. Louis R, et al. J Allergy Clin Immunol Pract. 2023 Jun;11(6):1759-1770.e7. doi: 10.1016/j.jaip.2023.03.009. Epub 2023 Mar 21. J Allergy Clin Immunol Pract. 2023. PMID: 36948488 Free article.
Achieving asthma control in practice: understanding the reasons for poor control.
Haughney J, Price D, Kaplan A, Chrystyn H, Horne R, May N, Moffat M, Versnel J, Shanahan ER, Hillyer EV, Tunsäter A, Bjermer L. Haughney J, et al. Among authors: tunsater a. Respir Med. 2008 Dec;102(12):1681-93. doi: 10.1016/j.rmed.2008.08.003. Epub 2008 Sep 23. Respir Med. 2008. PMID: 18815019 Free article. Review.
A new protocol for exercise testing in COPD; improved prediction algorithm for WMAX and validation of the endurance test in a placebo-controlled double bronchodilator study.
Tufvesson E, Radner F, Simonsen A, Papapostolou G, Jarenbäck L, Jönsson S, Nihlen U, Tunsäter A, Ankerst J, Peterson S, Bjermer L, Eriksson G. Tufvesson E, et al. Among authors: tunsater a. Ther Adv Respir Dis. 2021 Jan-Dec;15:17534666211037454. doi: 10.1177/17534666211037454. Ther Adv Respir Dis. 2021. PMID: 34590519 Free PMC article.
35 results